Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Lui Shiong Lee is a pioneering urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for bladder and prostate cancers. His major contributions lie in demonstrating the superiority of robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion over traditional open surgery, particularly within Enhanced Recovery After Surgery (ERAS) programs. Through the Asian RARC Consortium, Dr. Lee has led multicenter studies—including one with 23 citations—showing that RARC reduces complications and hospital stays while maintaining oncological outcomes. His research on long-term outcomes comparing orthotopic neobladder versus ileal conduit diversion (12 citations) provides critical guidance for patient selection. In prostate cancer, Dr. Lee has pioneered the use of multiparametric MRI-ultrasonography fusion with a stereotactic robotic-assisted transperineal platform (23 citations), improving diagnostic accuracy by comparing systematic versus targeted biopsy. With over 80 cumulative citations across his most-cited works, Dr. Lee’s impact is evident in shaping minimally invasive urologic oncology standards. His leadership in the Asian RARC Consortium and contributions to evidence-based surgical innovation make him a key figure in advancing robotic urology.